Status:
TERMINATED
Diabetes-Obstructive Sleep Apnea Treatment Trial
Lead Sponsor:
Eileen R. Chasens
Conditions:
Type 2 Diabetes
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diabetes self-management is important to help adults with type 2 diabetes achieve glucose control. Obstructive sleep apnea often co-exists with type 2 diabetes and may act as a barrier to diabetes sel...
Detailed Description
While diabetes self-management has been improved and refined over the last 30 years, many persons with T2DM continue to have difficulty in achieving glycemic goals. Obstructive sleep apnea (OSA) has a...
Eligibility Criteria
Inclusion
- Suboptimal glucose control (A1C ≥ 6.5%)
- Moderate-to-severe obstructive sleep apnea (apnea + hypopnea index \>= 10/hour)
- age 18 years and older
Exclusion
- Poor glucose control (A1C \> 11)
- Type 1 or gestational diabetes
- Sleep duration \< 4 hrs
- Acute medical or surgical conditions or hospitalization ≤ 3 months
- Oxygen or bi-level PAP required
- Prior CPAP or persons in household with CPAP
- Employed in safety sensitive job
- Pregnant
Key Trial Info
Start Date :
February 13 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 8 2019
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT01901055
Start Date
February 13 2014
End Date
May 8 2019
Last Update
August 16 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
John D. Dingell VAMC
Detroit, Michigan, United States, 48201
2
Pittsburgh Veterans Administration Medical Center
Pittsburgh, Pennsylvania, United States, 15240
3
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
4
West Virginia University
Morgantown, West Virginia, United States, 26506